← Leaderboards
Ryan Edward Looper
Harvard University
$4,223,163
Attributed
$4,223,163
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $678.6K · FY2006–20$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$4,223,163 · 3
By mechanism
R01$4,145,806 · 2
F32$77,357 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Structure”
- David Heimbrook · Leidos Biomedical Research, Inc.$475,333,582
- Barton F Haynes · Duke University$444,977,767
- Lawrence Corey · Fred Hutchinson Cancer Center$334,646,086
- Gary D Acton · University Of California-Davis$320,373,312
- Mitchell J Malone · Texas A&M Research Foundation$320,373,312
- Michael David Hughes · Harvard University D/B/A Harvard School Of Public Health$315,257,203
Research focus
StructureInhibitor/AntagonistLaboratoriesBaseAnalogGuanidinesCellsNitrogenMethodologyPositioning AttributeMatrix Metalloproteinase InhibitorMatrix MetalloproteinasesAminesNaamidine AIn VivoAnchorage-Independent GrowthInvestigationArchitectureBiologicalChemistryDesignMalignant NeoplasmsFamilyNovel Strategies
Grant awards (17)
Development of Selective Ribosomal P-site Inhibitors$381,250
R01 · FY2020 · AI · contact PI
Development of Selective Ribosomal P-site Inhibitors$381,250
R01 · FY2019 · AI · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural products.$297,375
R01 · FY2019 · GM · contact PI
Development of Selective Ribosomal P-site Inhibitors$379,792
R01 · FY2018 · AI · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural products.$297,051
R01 · FY2018 · GM · contact PI
Development of Selective Ribosomal P-site Inhibitors$378,021
R01 · FY2017 · AI · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural products.$295,263
R01 · FY2017 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural products.$199,773
R01 · FY2016 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural produ$93,423
R01 · FY2016 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural produ$280,269
R01 · FY2014 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural produ$270,611
R01 · FY2013 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural produ$281,210
R01 · FY2012 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural produ$295,723
R01 · FY2011 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural produ$285,950
R01 · FY2010 · GM · contact PI
Synthetic and biological investigations of 2-aminoimidazole derived natural produ$28,845
R01 · FY2010 · GM · contact PI
Development of Potential Peptidylarginine Deiminase Inhibitors$31,381
F32 · FY2007 · GM · contact PI
Development of Potential Peptidylarginine Deiminase Inhibitors$45,976
F32 · FY2006 · GM · contact PI